Sadatoshi Maeda

Sadatoshi Maeda

Auto-generated profile, based on publicly available information

Sadatoshi Maeda

The United Graduate School of Veterinary Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2016 in Veterinary Dermatology
Verified
Journal Article
Closed access
PDF file
RARyota Asahina
Ryota Asahina
SMSadatoshi Maeda
Sadatoshi Maeda

17 September 2020 in Veterinary Dermatology
Verified
Journal Article
Open access
PDF file
RARyota Asahina
Ryota Asahina
KUKazunori Ueda
Kazunori Ueda
YOYuri Oshima
Yuri Oshima
TKToshitaka Kanei
Toshitaka Kanei
MKMasahiro Kato
Masahiro Kato
SMSadatoshi Maeda
Sadatoshi Maeda
Résumé: Contexte: La TARC/CCL17 (thymus and activation‐regulated chemokine) a été impliquée dans la pathogénie de la dermatite atopique canine (cAD). Les concentrations sériques de TARC sont un biomarqueur fiable chez l’homme atopique ; cependant, leur potentiel en tant que biomarqueur pour cAD n’a pas été étudié.Hypothèses/Objectifs: Etudier si les concentrations sériques de TARC corrèlent avec la sévérité de la maladie et les réponses thérapeutiques pour cAD.Sujets: Trente – neuf chiens avec cAD et 42 chiens sains ont été inclus.Matériels et méthodes: Les concentrations sériques en TARC chez les chiens avec cAD et les chiens sains ont été mesurées par ELISA avec anticorps anti‐TARC canin. La sévérité clinique de cAD a été notée par CADESI‐04 (Canine Atopic Dermatitis Extent and Severity Index, 4th iteration). Les concentrations de TARC sériques ont été comparées entre les chiens avec cAD et les chiens sains contrôles, et leur relation avec CADESI‐04 a été étudiée. Les concentrations sériques de TARC ont aussi été mesurées chez 20 chiens avec cAD traités par prednisolone ou oclacitinib pendant quatre semaines.Résultats: Les concentrations sériques de TARC étaient significativement plus élevées chez les chiens avec cAD que chez les chiens sains (P < 0.001). Chez les chiens avec cAD, les concentrations sériques de TARC corrélaient avec les scores de CADESI‐04 (ρ = 0.457, P< 0.01). En outre, les concentrations sériques de TARC diminuaient significativement chez les chiens traités avec atténuation des signes cliniques (P < 0.001). Les changements de concentrations sériques de TARC avant et après traitement corrélaient avec ceux des scores CADESI‐04 (ρ = 0.746, P < 0.001).Conclusions et importance clinique: Les concentrations sériques de TARC ont le potentiel d’être un outil clinique et de recherche pour l’évaluation objective de l’intensité de la maladie et de la réponse thérapeutique de la CAD.

2 March 2018 in Veterinary Dermatology
Verified
Journal Article
Closed access
PDF file
RARyota Asahina
Ryota Asahina
HNHidetaka Nishida
Hidetaka Nishida
HKHiroaki Kamishina
Hiroaki Kamishina
SMSadatoshi Maeda
Sadatoshi Maeda

28 March 2016 in Veterinary Dermatology
Verified
Journal Article
Closed access
PDF file
MSMayu Sakamoto
Mayu Sakamoto
RARyota Asahina
Ryota Asahina
HKHiroaki Kamishina
Hiroaki Kamishina
SMSadatoshi Maeda
Sadatoshi Maeda

1 January 2008 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
SSSanae Shibata
Sanae Shibata
SMSadatoshi Maeda
Sadatoshi Maeda
HTHiromi Tsuchida
Hiromi Tsuchida
TFTsuneo Fukata
Tsuneo Fukata
Epidermal keratinocytes have the potential to produce inflammatory mediators that are considered to play an important role in skin diseases such as atopic dermatitis (AD). Thus, cell lines of canine epidermal keratinocytes are useful for studying the biological reactivity of keratinocytes in vitro. However, there has been no report on properly analyzing the phenotype of canine keratinocyte cell lines. In this work, we performed phenotypic analysis of CPEK, which was derived from the epidermis of an adult dog in order to examine the phenotypic similarity with epidermal keratinocytes. The present findings indicated that CPEK cells expressed markers for epidermal keratinocytes including cytokeratin 14, α6 integrin and PCNA. Our findings demonstrated that CPEK could be a useful cell line for investigating the central role of epidermal keratinocytes in the pathogenesis of AD in vitro.

12 September 2021 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
YKYui Kobatake
Yui Kobatake
KNKohei Nakata
Kohei Nakata
HSHiroki Sakai
Hiroki Sakai
JSJun Sasaki
Jun Sasaki
OYOsamu Yamato
Osamu Yamato
HKHiroaki Kamishina
Hiroaki Kamishina
Canine degenerative myelopathy (DM), recognized as a spontaneous model of amyotrophic lateral sclerosis, is known as a late-onset progressive degenerative disease of the spinal cord. Because of the progressive nature of DM, many dogs are elected to be euthanized, resulting in limited information on the end-stage clinical presentation. We investigated the long-term clinical course from diagnosis to natural death to further deepen our understanding of the entire clinical picture of this disease. Because curcumin was administered in some cases, the therapeutic effect of curcumin on DM was also examined. Forty dogs included in this study were client-owned Pembroke Welsh Corgis with a definitive diagnosis of DM by necropsy and histopathology. Dogs were excluded from this study if they died from another disease or were elected to be euthanized. Information on the long-term clinical symptoms of DM was investigated based on a questionnaire, which was collected from the dog owners. Urinary incontinence and respiratory disorder were observed in most dogs, as was respiratory impairment-correlated death. In contrast, signs consistent with brainstem dysfunction were noticed at the terminal stage in a small portion of dogs. Although further studies with more cases are needed, the results of this study suggest that administration of curcumin is effective in slowing the progression of DM.